抗うつ薬のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Anti Depression Drugs Market Insights, Forecast to 2028

• レポートコード：QY2203B09204 • 出版社/出版日：QYResearch / 2022年3月 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の抗うつ薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に抗うつ薬の世界市場のxxx％を占める「粒」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「大うつ病性障害」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の抗うつ薬の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの抗うつ薬市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの抗うつ薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 抗うつ薬のグローバル主要メーカーには、Alkermes、Allergan、Bristol Myers Squibb、Eli Lilly and Company、GlaxoSmithKline、H. Lundbeck、Merck、Pfizer、Teva Pharmaceutical Industries、Takeda Pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 抗うつ薬市場は、種類と用途によって区分されます。世界の抗うつ薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 粒、カプセル 【用途別セグメント】 大うつ病性障害、強迫性障害、全般性不安障害、パニック障害 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 抗うつ薬製品概要 - 種類別市場（粒、カプセル） - 用途別市場（大うつ病性障害、強迫性障害、全般性不安障害、パニック障害） - 調査の目的 ・エグゼクティブサマリー - 世界の抗うつ薬販売量予測2017-2028 - 世界の抗うつ薬売上予測2017-2028 - 抗うつ薬の地域別販売量 - 抗うつ薬の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別抗うつ薬販売量 - 主要メーカー別抗うつ薬売上 - 主要メーカー別抗うつ薬価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（粒、カプセル） - 抗うつ薬の種類別販売量 - 抗うつ薬の種類別売上 - 抗うつ薬の種類別価格 ・用途別市場規模（大うつ病性障害、強迫性障害、全般性不安障害、パニック障害） - 抗うつ薬の用途別販売量 - 抗うつ薬の用途別売上 - 抗うつ薬の用途別価格 ・北米市場 - 北米の抗うつ薬市場規模（種類別、用途別） - 主要国別の抗うつ薬市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの抗うつ薬市場規模（種類別、用途別） - 主要国別の抗うつ薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の抗うつ薬市場規模（種類別、用途別） - 主要国別の抗うつ薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の抗うつ薬市場規模（種類別、用途別） - 主要国別の抗うつ薬市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの抗うつ薬市場規模（種類別、用途別） - 主要国別の抗うつ薬市場規模（トルコ、サウジアラビア） ・企業情報 Alkermes、Allergan、Bristol Myers Squibb、Eli Lilly and Company、GlaxoSmithKline、H. Lundbeck、Merck、Pfizer、Teva Pharmaceutical Industries、Takeda Pharmaceutical ・産業チェーン及び販売チャネル分析 - 抗うつ薬の産業チェーン分析 - 抗うつ薬の原材料 - 抗うつ薬の生産プロセス - 抗うつ薬の販売及びマーケティング - 抗うつ薬の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 抗うつ薬の産業動向 - 抗うつ薬のマーケットドライバー - 抗うつ薬の課題 - 抗うつ薬の阻害要因 ・主な調査結果

Drugs used to prevent and treat depression, such as tricyclic antidepressants, selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, monoamine oxidase inhibitors, serotonin antagonists and reuptake inhibitors.
Market Analysis and Insights: Global Anti Depression Drugs Market
Due to the COVID-19 pandemic, the global Anti Depression Drugs market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Grain accounting for % of the Anti Depression Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Major Depressive Disorder segment is altered to an % CAGR throughout this forecast period.
China Anti Depression Drugs market size is valued at US$ million in 2021, while the US and Europe Anti Depression Drugs are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Anti Depression Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Anti Depression Drugs include Alkermes, Allergan, Bristol Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, H. Lundbeck, Merck, Pfizer and Teva Pharmaceutical Industries and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Anti Depression Drugs Scope and Segment
Anti Depression Drugs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Anti Depression Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Grain
Capsule
Segment by Application
Major Depressive Disorder
Obsessive-Compulsive Disorder
Generalized Anxiety Disorder
Panic Disorder
By Company
Alkermes
Allergan
Bristol Myers Squibb
Eli Lilly and Company
GlaxoSmithKline
H. Lundbeck
Merck
Pfizer
Teva Pharmaceutical Industries
Takeda Pharmaceutical
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Anti Depression Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Anti Depression Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Grain
1.2.3 Capsule
1.3 Market by Application
1.3.1 Global Anti Depression Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Major Depressive Disorder
1.3.3 Obsessive-Compulsive Disorder
1.3.4 Generalized Anxiety Disorder
1.3.5 Panic Disorder
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Anti Depression Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Anti Depression Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Anti Depression Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Anti Depression Drugs Sales by Region
2.4.1 Global Anti Depression Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Anti Depression Drugs by Region (2023-2028)
2.5 Global Anti Depression Drugs Revenue by Region
2.5.1 Global Anti Depression Drugs Revenue by Region (2017-2022)
2.5.2 Global Anti Depression Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Anti Depression Drugs Sales by Manufacturers
3.1.1 Global Top Anti Depression Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Anti Depression Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anti Depression Drugs in 2021
3.2 Global Anti Depression Drugs Revenue by Manufacturers
3.2.1 Global Anti Depression Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Anti Depression Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Anti Depression Drugs Revenue in 2021
3.3 Global Anti Depression Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Anti Depression Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Anti Depression Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Anti Depression Drugs Sales by Type
4.1.1 Global Anti Depression Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Anti Depression Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Anti Depression Drugs Sales Market Share by Type (2017-2028)
4.2 Global Anti Depression Drugs Revenue by Type
4.2.1 Global Anti Depression Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Anti Depression Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Anti Depression Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Anti Depression Drugs Price by Type
4.3.1 Global Anti Depression Drugs Price by Type (2017-2022)
4.3.2 Global Anti Depression Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Anti Depression Drugs Sales by Application
5.1.1 Global Anti Depression Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Anti Depression Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Anti Depression Drugs Sales Market Share by Application (2017-2028)
5.2 Global Anti Depression Drugs Revenue by Application
5.2.1 Global Anti Depression Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Anti Depression Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Anti Depression Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Anti Depression Drugs Price by Application
5.3.1 Global Anti Depression Drugs Price by Application (2017-2022)
5.3.2 Global Anti Depression Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Anti Depression Drugs Market Size by Type
6.1.1 North America Anti Depression Drugs Sales by Type (2017-2028)
6.1.2 North America Anti Depression Drugs Revenue by Type (2017-2028)
6.2 North America Anti Depression Drugs Market Size by Application
6.2.1 North America Anti Depression Drugs Sales by Application (2017-2028)
6.2.2 North America Anti Depression Drugs Revenue by Application (2017-2028)
6.3 North America Anti Depression Drugs Market Size by Country
6.3.1 North America Anti Depression Drugs Sales by Country (2017-2028)
6.3.2 North America Anti Depression Drugs Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Anti Depression Drugs Market Size by Type
7.1.1 Europe Anti Depression Drugs Sales by Type (2017-2028)
7.1.2 Europe Anti Depression Drugs Revenue by Type (2017-2028)
7.2 Europe Anti Depression Drugs Market Size by Application
7.2.1 Europe Anti Depression Drugs Sales by Application (2017-2028)
7.2.2 Europe Anti Depression Drugs Revenue by Application (2017-2028)
7.3 Europe Anti Depression Drugs Market Size by Country
7.3.1 Europe Anti Depression Drugs Sales by Country (2017-2028)
7.3.2 Europe Anti Depression Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Anti Depression Drugs Market Size by Type
8.1.1 Asia Pacific Anti Depression Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Anti Depression Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Anti Depression Drugs Market Size by Application
8.2.1 Asia Pacific Anti Depression Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Anti Depression Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Anti Depression Drugs Market Size by Region
8.3.1 Asia Pacific Anti Depression Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Anti Depression Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Anti Depression Drugs Market Size by Type
9.1.1 Latin America Anti Depression Drugs Sales by Type (2017-2028)
9.1.2 Latin America Anti Depression Drugs Revenue by Type (2017-2028)
9.2 Latin America Anti Depression Drugs Market Size by Application
9.2.1 Latin America Anti Depression Drugs Sales by Application (2017-2028)
9.2.2 Latin America Anti Depression Drugs Revenue by Application (2017-2028)
9.3 Latin America Anti Depression Drugs Market Size by Country
9.3.1 Latin America Anti Depression Drugs Sales by Country (2017-2028)
9.3.2 Latin America Anti Depression Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Anti Depression Drugs Market Size by Type
10.1.1 Middle East and Africa Anti Depression Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Anti Depression Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Anti Depression Drugs Market Size by Application
10.2.1 Middle East and Africa Anti Depression Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Anti Depression Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Anti Depression Drugs Market Size by Country
10.3.1 Middle East and Africa Anti Depression Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Anti Depression Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Alkermes
11.1.1 Alkermes Corporation Information
11.1.2 Alkermes Overview
11.1.3 Alkermes Anti Depression Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Alkermes Anti Depression Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Alkermes Recent Developments
11.2 Allergan
11.2.1 Allergan Corporation Information
11.2.2 Allergan Overview
11.2.3 Allergan Anti Depression Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Allergan Anti Depression Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Allergan Recent Developments
11.3 Bristol Myers Squibb
11.3.1 Bristol Myers Squibb Corporation Information
11.3.2 Bristol Myers Squibb Overview
11.3.3 Bristol Myers Squibb Anti Depression Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bristol Myers Squibb Anti Depression Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bristol Myers Squibb Recent Developments
11.4 Eli Lilly and Company
11.4.1 Eli Lilly and Company Corporation Information
11.4.2 Eli Lilly and Company Overview
11.4.3 Eli Lilly and Company Anti Depression Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Eli Lilly and Company Anti Depression Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Eli Lilly and Company Recent Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Corporation Information
11.5.2 GlaxoSmithKline Overview
11.5.3 GlaxoSmithKline Anti Depression Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 GlaxoSmithKline Anti Depression Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GlaxoSmithKline Recent Developments
11.6 H. Lundbeck
11.6.1 H. Lundbeck Corporation Information
11.6.2 H. Lundbeck Overview
11.6.3 H. Lundbeck Anti Depression Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 H. Lundbeck Anti Depression Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 H. Lundbeck Recent Developments
11.7 Merck
11.7.1 Merck Corporation Information
11.7.2 Merck Overview
11.7.3 Merck Anti Depression Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Merck Anti Depression Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Merck Recent Developments
11.8 Pfizer
11.8.1 Pfizer Corporation Information
11.8.2 Pfizer Overview
11.8.3 Pfizer Anti Depression Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Pfizer Anti Depression Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Pfizer Recent Developments
11.9 Teva Pharmaceutical Industries
11.9.1 Teva Pharmaceutical Industries Corporation Information
11.9.2 Teva Pharmaceutical Industries Overview
11.9.3 Teva Pharmaceutical Industries Anti Depression Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Teva Pharmaceutical Industries Anti Depression Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Teva Pharmaceutical Industries Recent Developments
11.10 Takeda Pharmaceutical
11.10.1 Takeda Pharmaceutical Corporation Information
11.10.2 Takeda Pharmaceutical Overview
11.10.3 Takeda Pharmaceutical Anti Depression Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Takeda Pharmaceutical Anti Depression Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Takeda Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Anti Depression Drugs Industry Chain Analysis
12.2 Anti Depression Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Anti Depression Drugs Production Mode & Process
12.4 Anti Depression Drugs Sales and Marketing
12.4.1 Anti Depression Drugs Sales Channels
12.4.2 Anti Depression Drugs Distributors
12.5 Anti Depression Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Anti Depression Drugs Industry Trends
13.2 Anti Depression Drugs Market Drivers
13.3 Anti Depression Drugs Market Challenges
13.4 Anti Depression Drugs Market Restraints
14 Key Findings in The Global Anti Depression Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Anti Depression Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Grain
Table 3. Major Manufacturers of Capsule
Table 4. Global Anti Depression Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Anti Depression Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Anti Depression Drugs Sales by Region (2017-2022) & (K Units)
Table 7. Global Anti Depression Drugs Sales Market Share by Region (2017-2022)
Table 8. Global Anti Depression Drugs Sales by Region (2023-2028) & (K Units)
Table 9. Global Anti Depression Drugs Sales Market Share by Region (2023-2028)
Table 10. Global Anti Depression Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Anti Depression Drugs Revenue Market Share by Region (2017-2022)
Table 12. Global Anti Depression Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Anti Depression Drugs Revenue Market Share by Region (2023-2028)
Table 14. Global Anti Depression Drugs Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Anti Depression Drugs Sales Share by Manufacturers (2017-2022)
Table 16. Global Anti Depression Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Anti Depression Drugs Revenue Share by Manufacturers (2017-2022)
Table 18. Anti Depression Drugs Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Anti Depression Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Anti Depression Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti Depression Drugs as of 2021)
Table 21. Anti Depression Drugs Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Anti Depression Drugs Product Offered
Table 23. Date of Manufacturers Enter into Anti Depression Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Anti Depression Drugs Sales by Type (2017-2022) & (K Units)
Table 26. Global Anti Depression Drugs Sales by Type (2023-2028) & (K Units)
Table 27. Global Anti Depression Drugs Sales Share by Type (2017-2022)
Table 28. Global Anti Depression Drugs Sales Share by Type (2023-2028)
Table 29. Global Anti Depression Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Anti Depression Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Anti Depression Drugs Revenue Share by Type (2017-2022)
Table 32. Global Anti Depression Drugs Revenue Share by Type (2023-2028)
Table 33. Anti Depression Drugs Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Anti Depression Drugs Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Anti Depression Drugs Sales by Application (2017-2022) & (K Units)
Table 36. Global Anti Depression Drugs Sales by Application (2023-2028) & (K Units)
Table 37. Global Anti Depression Drugs Sales Share by Application (2017-2022)
Table 38. Global Anti Depression Drugs Sales Share by Application (2023-2028)
Table 39. Global Anti Depression Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Anti Depression Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Anti Depression Drugs Revenue Share by Application (2017-2022)
Table 42. Global Anti Depression Drugs Revenue Share by Application (2023-2028)
Table 43. Anti Depression Drugs Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Anti Depression Drugs Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Anti Depression Drugs Sales by Type (2017-2022) & (K Units)
Table 46. North America Anti Depression Drugs Sales by Type (2023-2028) & (K Units)
Table 47. North America Anti Depression Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Anti Depression Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Anti Depression Drugs Sales by Application (2017-2022) & (K Units)
Table 50. North America Anti Depression Drugs Sales by Application (2023-2028) & (K Units)
Table 51. North America Anti Depression Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Anti Depression Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Anti Depression Drugs Sales by Country (2017-2022) & (K Units)
Table 54. North America Anti Depression Drugs Sales by Country (2023-2028) & (K Units)
Table 55. North America Anti Depression Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Anti Depression Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Anti Depression Drugs Sales by Type (2017-2022) & (K Units)
Table 58. Europe Anti Depression Drugs Sales by Type (2023-2028) & (K Units)
Table 59. Europe Anti Depression Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Anti Depression Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Anti Depression Drugs Sales by Application (2017-2022) & (K Units)
Table 62. Europe Anti Depression Drugs Sales by Application (2023-2028) & (K Units)
Table 63. Europe Anti Depression Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Anti Depression Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Anti Depression Drugs Sales by Country (2017-2022) & (K Units)
Table 66. Europe Anti Depression Drugs Sales by Country (2023-2028) & (K Units)
Table 67. Europe Anti Depression Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Anti Depression Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Anti Depression Drugs Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Anti Depression Drugs Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Anti Depression Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Anti Depression Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Anti Depression Drugs Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Anti Depression Drugs Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Anti Depression Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Anti Depression Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Anti Depression Drugs Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Anti Depression Drugs Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Anti Depression Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Anti Depression Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Anti Depression Drugs Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Anti Depression Drugs Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Anti Depression Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Anti Depression Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Anti Depression Drugs Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Anti Depression Drugs Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Anti Depression Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Anti Depression Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Anti Depression Drugs Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Anti Depression Drugs Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Anti Depression Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Anti Depression Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Anti Depression Drugs Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Anti Depression Drugs Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Anti Depression Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Anti Depression Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Anti Depression Drugs Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Anti Depression Drugs Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Anti Depression Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Anti Depression Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Anti Depression Drugs Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Anti Depression Drugs Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Anti Depression Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Anti Depression Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 105. Alkermes Corporation Information
Table 106. Alkermes Description and Major Businesses
Table 107. Alkermes Anti Depression Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Alkermes Anti Depression Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Alkermes Recent Developments
Table 110. Allergan Corporation Information
Table 111. Allergan Description and Major Businesses
Table 112. Allergan Anti Depression Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. Allergan Anti Depression Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Allergan Recent Developments
Table 115. Bristol Myers Squibb Corporation Information
Table 116. Bristol Myers Squibb Description and Major Businesses
Table 117. Bristol Myers Squibb Anti Depression Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. Bristol Myers Squibb Anti Depression Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Bristol Myers Squibb Recent Developments
Table 120. Eli Lilly and Company Corporation Information
Table 121. Eli Lilly and Company Description and Major Businesses
Table 122. Eli Lilly and Company Anti Depression Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. Eli Lilly and Company Anti Depression Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Eli Lilly and Company Recent Developments
Table 125. GlaxoSmithKline Corporation Information
Table 126. GlaxoSmithKline Description and Major Businesses
Table 127. GlaxoSmithKline Anti Depression Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. GlaxoSmithKline Anti Depression Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. GlaxoSmithKline Recent Developments
Table 130. H. Lundbeck Corporation Information
Table 131. H. Lundbeck Description and Major Businesses
Table 132. H. Lundbeck Anti Depression Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. H. Lundbeck Anti Depression Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. H. Lundbeck Recent Developments
Table 135. Merck Corporation Information
Table 136. Merck Description and Major Businesses
Table 137. Merck Anti Depression Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. Merck Anti Depression Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Merck Recent Developments
Table 140. Pfizer Corporation Information
Table 141. Pfizer Description and Major Businesses
Table 142. Pfizer Anti Depression Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 143. Pfizer Anti Depression Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Pfizer Recent Developments
Table 145. Teva Pharmaceutical Industries Corporation Information
Table 146. Teva Pharmaceutical Industries Description and Major Businesses
Table 147. Teva Pharmaceutical Industries Anti Depression Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 148. Teva Pharmaceutical Industries Anti Depression Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Teva Pharmaceutical Industries Recent Developments
Table 150. Takeda Pharmaceutical Corporation Information
Table 151. Takeda Pharmaceutical Description and Major Businesses
Table 152. Takeda Pharmaceutical Anti Depression Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 153. Takeda Pharmaceutical Anti Depression Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Takeda Pharmaceutical Recent Developments
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Anti Depression Drugs Distributors List
Table 158. Anti Depression Drugs Customers List
Table 159. Anti Depression Drugs Market Trends
Table 160. Anti Depression Drugs Market Drivers
Table 161. Anti Depression Drugs Market Challenges
Table 162. Anti Depression Drugs Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti Depression Drugs Product Picture
Figure 3. Global Anti Depression Drugs Market Share by Type in 2021 & 2028
Figure 3. Grain Product Picture
Figure 4. Capsule Product Picture
Figure 5. Global Anti Depression Drugs Market Share by Application in 2021 & 2028
Figure 6. Major Depressive Disorder
Figure 7. Obsessive-Compulsive Disorder
Figure 8. Generalized Anxiety Disorder
Figure 9. Panic Disorder
Figure 10. Anti Depression Drugs Report Years Considered
Figure 11. Global Anti Depression Drugs Sales 2017-2028 (K Units)
Figure 12. Global Anti Depression Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Anti Depression Drugs Revenue 2017-2028 (US$ Million)
Figure 14. Global Anti Depression Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Anti Depression Drugs Sales Market Share by Region (2017-2022)
Figure 16. Global Anti Depression Drugs Sales Market Share by Region (2023-2028)
Figure 17. North America Anti Depression Drugs Sales YoY (2017-2028) & (K Units)
Figure 18. North America Anti Depression Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Anti Depression Drugs Sales YoY (2017-2028) & (K Units)
Figure 20. Europe Anti Depression Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Anti Depression Drugs Sales YoY (2017-2028) & (K Units)
Figure 22. Asia-Pacific Anti Depression Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Anti Depression Drugs Sales YoY (2017-2028) & (K Units)
Figure 24. Latin America Anti Depression Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Anti Depression Drugs Sales YoY (2017-2028) & (K Units)
Figure 26. Middle East & Africa Anti Depression Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Anti Depression Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Anti Depression Drugs in the World: Market Share by Anti Depression Drugs Revenue in 2021
Figure 29. Global Anti Depression Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Anti Depression Drugs Sales Market Share by Type (2017-2028)
Figure 31. Global Anti Depression Drugs Revenue Market Share by Type (2017-2028)
Figure 32. Global Anti Depression Drugs Sales Market Share by Application (2017-2028)
Figure 33. Global Anti Depression Drugs Revenue Market Share by Application (2017-2028)
Figure 34. North America Anti Depression Drugs Sales Market Share by Type (2017-2028)
Figure 35. North America Anti Depression Drugs Revenue Market Share by Type (2017-2028)
Figure 36. North America Anti Depression Drugs Sales Market Share by Application (2017-2028)
Figure 37. North America Anti Depression Drugs Revenue Market Share by Application (2017-2028)
Figure 38. North America Anti Depression Drugs Sales Share by Country (2017-2028)
Figure 39. North America Anti Depression Drugs Revenue Share by Country (2017-2028)
Figure 40. United States Anti Depression Drugs Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Anti Depression Drugs Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Anti Depression Drugs Sales Market Share by Type (2017-2028)
Figure 43. Europe Anti Depression Drugs Revenue Market Share by Type (2017-2028)
Figure 44. Europe Anti Depression Drugs Sales Market Share by Application (2017-2028)
Figure 45. Europe Anti Depression Drugs Revenue Market Share by Application (2017-2028)
Figure 46. Europe Anti Depression Drugs Sales Share by Country (2017-2028)
Figure 47. Europe Anti Depression Drugs Revenue Share by Country (2017-2028)
Figure 48. Germany Anti Depression Drugs Revenue (2017-2028) & (US$ Million)
Figure 49. France Anti Depression Drugs Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Anti Depression Drugs Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Anti Depression Drugs Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Anti Depression Drugs Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Anti Depression Drugs Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Anti Depression Drugs Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Anti Depression Drugs Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Anti Depression Drugs Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Anti Depression Drugs Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Anti Depression Drugs Revenue Share by Region (2017-2028)
Figure 59. China Anti Depression Drugs Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Anti Depression Drugs Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Anti Depression Drugs Revenue (2017-2028) & (US$ Million)
Figure 62. India Anti Depression Drugs Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Anti Depression Drugs Revenue (2017-2028) & (US$ Million)
Figure 64. China Taiwan Anti Depression Drugs Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Anti Depression Drugs Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Anti Depression Drugs Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Anti Depression Drugs Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Anti Depression Drugs Sales Market Share by Type (2017-2028)
Figure 69. Latin America Anti Depression Drugs Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Anti Depression Drugs Sales Market Share by Application (2017-2028)
Figure 71. Latin America Anti Depression Drugs Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Anti Depression Drugs Sales Share by Country (2017-2028)
Figure 73. Latin America Anti Depression Drugs Revenue Share by Country (2017-2028)
Figure 74. Mexico Anti Depression Drugs Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Anti Depression Drugs Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Anti Depression Drugs Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Anti Depression Drugs Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Anti Depression Drugs Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Anti Depression Drugs Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Anti Depression Drugs Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Anti Depression Drugs Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Anti Depression Drugs Revenue Share by Country (2017-2028)
Figure 83. Turkey Anti Depression Drugs Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Anti Depression Drugs Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Anti Depression Drugs Revenue (2017-2028) & (US$ Million)
Figure 86. Anti Depression Drugs Value Chain
Figure 87. Anti Depression Drugs Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

---